Back
Parametric Equity Premium Income ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
68
PAPI
Parametric Equity Premium Income ETF
Last Price:
$26.24
Seasonality Move:
4.07%
Sell
39
INKT
MiNK Therapeutics, Inc.
Last Price:
$12.42
Seasonality Move:
-18.07%
Buy
68
Parametric Equity Premium Income ETF (PAPI)
is a Buy
Is Parametric Equity Premium Income ETF a Buy, Sell or Hold?
-
The current Parametric Equity Premium Income ETF [PAPI] share price is $26.26. The Score for PAPI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
PAPI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $12.42. The Score for INKT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PAPI Stock Price Chart
What is Parametric Equity Premium Income ETF's stock price today?
-
The Parametric Equity Premium Income ETF share price today is $26.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAPI is experiencing slight selling pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $12.42The current trend is relatively stagnant and INKT is experiencing slight selling pressure.
PAPI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 61.34 | Buy |
| Chaikin Money Flow: | -8761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.58 - 26.1) | Buy |
| Bollinger Bands (100): | (25.49 - 26.15) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 51.41 | Buy |
| Chaikin Money Flow: | -4658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.9 - 13.02) | Buy |
| Bollinger Bands (100): | (12.31 - 15.67) | Sell |
PAPI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.05 | Buy |
| 20-day SMA: | 25.86 | Buy |
| 50-day SMA: | 25.77 | Buy |
| 200-day SMA: | 25.74 | Buy |
| 8-day EMA: | 26.09 | Buy |
| 20-day EMA: | 25.93 | Buy |
| 50-day EMA: | 25.28 | Buy |
| 200-day EMA: | 15.93 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.19 | Buy |
| 20-day SMA: | 11.57 | Buy |
| 50-day SMA: | 13.1 | Sell |
| 200-day SMA: | 11.81 | Buy |
| 8-day EMA: | 12.21 | Buy |
| 20-day EMA: | 12.1 | Buy |
| 50-day EMA: | 12.78 | Sell |
| 200-day EMA: | 12.24 | Buy |
Parametric Equity Premium Income ETF Earnings Growth & PAPI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Parametric Equity Premium Income ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||